SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 162 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2016. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $8,920,000 | -87.2% | 4,000,000 | -83.4% | 0.17% | -86.1% |
| Q3 2017 | $69,781,000 | -34.9% | 24,062,368 | -0.1% | 1.25% | -13.5% |
| Q2 2017 | $107,195,000 | -4.5% | 24,088,655 | 0.0% | 1.45% | -2.8% |
| Q1 2017 | $112,253,000 | -23.5% | 24,088,655 | 0.0% | 1.49% | -19.4% |
| Q4 2016 | $146,700,000 | +9.9% | 24,088,655 | -0.6% | 1.85% | +27.8% |
| Q3 2016 | $133,500,000 | +26.6% | 24,228,655 | -12.7% | 1.45% | +35.0% |
| Q2 2016 | $105,475,000 | +244.6% | 27,756,668 | +150.3% | 1.07% | +374.3% |
| Q1 2016 | $30,608,000 | -40.0% | 11,090,000 | +23.2% | 0.23% | -25.9% |
| Q4 2015 | $51,030,000 | +7.0% | 9,000,000 | 0.0% | 0.30% | +23.0% |
| Q3 2015 | $47,700,000 | -0.6% | 9,000,000 | +55.7% | 0.25% | +12.2% |
| Q2 2015 | $47,986,000 | +395.6% | 5,781,500 | +175.9% | 0.22% | +351.0% |
| Q1 2015 | $9,682,000 | – | 2,095,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 1,767,858 | $3,235,000 | 4.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,505,809 | $2,726,000 | 1.06% |
| Nantahala Capital Management | 11,578,568 | $21,189,000 | 0.96% |
| Hikari Power Ltd | 2,000,000 | $3,660,000 | 0.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,376,708 | $2,519,000 | 0.20% |
| KNOTT DAVID M | 225,400 | $412,000 | 0.17% |
| Truepoint, Inc. | 37 | $20,000,000 | 0.16% |
| Clear Harbor Asset Management, LLC | 283,560 | $519,000 | 0.10% |
| Malaga Cove Capital, LLC | 97,266 | $178,000 | 0.10% |
| Lehman Financial Resources, Inc. | 70,800 | $129,000 | 0.07% |